Apogee Therapeutics, Inc. (APGE)
75.66
+0.18
(+0.24%)
USD |
NASDAQ |
Jan 02, 16:00
75.66
0.00 (0.00%)
After-Hours: 20:00
Apogee Therapeutics Shareholders Equity (Quarterly): 586.34M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.619B |
| Nektar Therapeutics | 85.09M |
| Regeneron Pharmaceuticals, Inc. | 30.96B |
| Aveanna Healthcare Holdings, Inc. | 9.184M |
| Turn Therapeutics, Inc. | 0.5567M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 626.16M |
| Total Liabilities (Quarterly) | 39.82M |
| Debt to Equity Ratio | 0.0168 |
| Current Ratio | 15.86 |
| Net Debt Paydown Yield | -0.05% |